共 180 条
[1]
Cruz-Jentoft AJ(2019)Sarcopenia: revised European consensus on definition and diagnosis Age Ageing 48 16-31
[2]
Bahat G(2019)Financial impact of sarcopenia or low muscle mass—a short review Clin Nutr 38 1489-1495
[3]
Bauer J(2004)The healthcare costs of sarcopenia in the United States J Am Geriatr Soc 52 80-85
[4]
Boirie Y(2022)Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis J Cachexia Sarcopenia Muscle 13 86-99
[5]
Bruyère O(2020)Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment J Am Med Dir Assoc 21 300-307.e2
[6]
Cederholm T(2014)Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia J Am Med Dir Assoc 15 95-101
[7]
Norman K(2010)Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People Age Ageing 39 412-423
[8]
Otten L(2011)Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia J Am Med Dir Assoc 12 249-256
[9]
Janssen I(2014)The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates J Gerontol A Biol Sci Med Sci 69 547-558
[10]
Shepard DS(2021)Diagnostic performance of clinical laboratory indicators with sarcopenia: results from the west china health and aging trend study Front Endocrinol (Lausanne) 12 785045-36